Platelet protein may explain blood clot risk for people with type 2 diabetes

New research from the Charles Perkins Center at the University of Sydney has uncovered a new biological pathway that may help explain why people with type 2 diabetes are more prone to developing dangerous blood clots, potentially paving the way for future treatments that reduce their cardiovascular risk.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup